The 26th Annual General Meeting of the Members of Wockhardt Limited will be held on Friday, 8th August, 2025 at 3:30 pm (IST), through Video Conferencing (VC)/ Other Audio Visual Means (OAVM).
WOCKPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Wockhardt Limited has scheduled its 26th AGM for Friday, August 8, 2025 at 3:30 PM IST, to be held via video conferencing. The agenda covers adoption of FY2024-25 audited standalone and consolidated financial statements, and re-appointment of Dr. Murtaza Khorakiwala (Managing Director) who retires by rotation. Key special business items include a proposal to raise up to ₹2,000 Crore through public, private, or Qualified Institutions Placement (QIP) routes — a move that could dilute existing shareholders. The company is also seeking shareholder approval to revise remuneration for both Executive Director Dr. Huzaifa Khorakiwala and Managing Director Dr. Murtaza Khorakiwala, setting a basic salary of ₹24 lakh/month with total compensation capped at ₹4 crore per annum (extendable up to ₹6 crore). Other items include approval of material related party transactions, re-appointment of Mr. Akhilesh Krishna Gupta as Independent Director for a second 5-year term (2025–2030), and appointment of a new Secretarial Auditor for 5 years. The e-voting window is August 5–7, 2025, with the record date set as August 1, 2025.
The proposed ₹2,000 Crore fundraise is the most material item — if approved and executed, it could lead to significant equity dilution and near-term pressure on the stock price. Higher executive remuneration (up to ₹6 Cr each for two directors) will increase fixed costs, though the company also retains flexibility to keep raises within SEBI limits. No dividend or earnings surprise is implied; this is a procedural and forward-looking capital structure decision.